Schedule 13G ownership disclosure
Cardiff Oncology Inc
Common Stock, $0.0001 par value per share · CUSIP: 14147L108
Event date: 2024-12-31
- Filing-level shares
- 2,411,575.00
- Percent of class
- 3.6%
- Pfizer Inc. 13-5315170
Shares: 2,411,575.00 · Class: 3.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-25-000040
- Form type
- SCHEDULE 13G/A
- Filer
- Cardiff Oncology, Inc.
- CIK
- CIK 1213037
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership